Carlos Lumbreras

Full Professor

Universidad Complutense de Madrid Facultad de Medicina

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Carlos Lumbreras is a Full Professor at Universidad Complutense de Madrid Facultad de Medicina, Spain. His research focuses on the impacts of SARS-CoV-2 infection and treatments, particularly concerning COVID-19 patient outcomes, including pain prevalence and thromboembolism risks. He has published extensively on antibiotic efficacy against resistant infections and the early identification of immunocompromising conditions in patients following invasive diseases.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (32)

Rocco Giordano

Aalborg University

DENMARK

Carlos Lumbreras

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prevalence of Post-COVID-19 Pain.

Efficacy of Ceftobiprole and Daptomycin at Bone Concentrations Against Methicillin-Resistant &lt;i&gt;Staphylococcus aureus&lt;/i&gt; Biofilm: Results of a Dynamic In Vitro PK/PD Model.

Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry.

Effectiveness of pharmacological treatments for COVID-19 due to SARS-CoV-2: a systematic literature review.

Periprosthetic Infection of Transfibular Ankle Arthroplasties Managed with Implant Retention: Anatomical Limitations of Surgical Debridement.

Searching for Immunocompromising Conditions in Low-risk Adults After Invasive Pneumococcal Disease: An Opportunity to Uncover Multiple Myeloma Early

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

Neurological manifestations of COVID-19 in adults and children

Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID-19 cohort.

Disparities between Latinx migrants and Spanish natives in COVID-19 outcome in Madrid

Enhancing screening adherence for strongyloides infection in latinx inpatients with COVID-19: a local protocol implementation study

Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19

COVID‐19 vaccines reduce mortality in hospitalized patients with oxygen requirements: Differences between vaccine subtypes. A multicontinental cohort study

Impact of days elapsed from the onset of symptoms to hospitalization in COVID-19 in-hospital mortality: time matters

Impacto de los días transcurridos desde el inicio de los síntomas hasta la hospitalización en la mortalidad hospitalaria por COVID-19: el tiempo importa

Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry.

Collaborators (32)

Rocco Giordano

Daniel Munblit

Maia Rabaa

Antonia Ho

Barbara Wanjiru Citarella

Brenda Molloy

Ilka Engelmann

Pallav Shah

Nicolas TERZI

John Laffey

Nicole White

Srinivas Murthy

Ahmed Sameh Said

Laura Merson

Melissa Joy Parker

Antonio Loforte

Ben Morton

Francisco Javier Carrasco-Sánchez

Ewen Harrison

Demetrios Kutsogiannis

Susanne Gjeruldsen Dudman

ISARIC Clinical Characterisation Group

João João Mendes

Eric D'Ortenzio

Kalynn Kennon

Amanda Rojek

D. J. Brewster

Anders Benjamin Kildal

Neel Shah

Nina Jamieson

Tjard Schermer

Victoria Janes

Make your next move.

Efficacy of Ceftobiprole and Daptomycin at Bone Concentrations Against Methicillin-Resistant <i>Staphylococcus aureus</i> Biofilm: Results of a Dynamic In Vitro PK/PD Model.